Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Management of Elevated INR Before Endoscopy

Risk Assessment

  • EGD is considered a low-risk endoscopic procedure when performed for diagnostic purposes with or without biopsy sampling 1, 2
  • An INR of 2.09 falls within the therapeutic range for most anticoagulation indications 3
  • For low-risk endoscopic procedures, guidelines recommend proceeding with the procedure if the INR is within the therapeutic range 1, 2

Management Recommendations

  • No need to withhold warfarin before the procedure as the INR is within therapeutic range 1, 3
  • The procedure can proceed as scheduled without delay 1, 2

Special Considerations

  • If the EGD is planned for therapeutic intervention, it would be considered a high-risk procedure, and different management might be needed 1, 2
  • For high-risk endoscopic procedures, an INR <1.5 is typically recommended, which would require temporary discontinuation of warfarin 1, 3
  • The patient's thromboembolic risk should be considered when making decisions about anticoagulation management 2, 6

Post-Procedure Management

  • Continue warfarin at the usual maintenance dose after the procedure 3
  • If any bleeding occurs during or after the procedure, management should include local hemostatic measures 2, 7

Common Pitfalls to Avoid

  • Unnecessarily withholding warfarin before low-risk procedures increases thromboembolic risk 1, 4
  • Administering vitamin K when not necessary can lead to warfarin resistance and difficulty re-establishing therapeutic anticoagulation 4, 5